Skip to main content
. 2021 May 28;8:647023. doi: 10.3389/fmed.2021.647023

Table 3.

(A) Numbers of patients with HA-AKI, CA-AKI, and no AKI and their mortality rates separated by general floor and ICU admission, and (B) adjusted mortality odds ratios for different groups.

Patients, no. (%)
HA-AKI CA-AKI No AKI p
(A)
Patient count
All admitted patients 308 (23.3%) 295 (22.3%) 721 (54.5%) b, c
General floor 269 (21.9%) 252 (20.6%) 705 (57.5%) b, c
Direct ICU admission 39 (39.8%) 43 (43.9%) 16 (16.3%) b, c
ICU upgrade 72 (36%) 104 (52%) 24 (12%) a, b, c
Non-upgrade general floor 197 (19.2%) 148 (14.4%) 681 (66.4%) a, b, c
Total ICU admission 111 (37.2%) 147 (49.3%) 40 (13.4%) a, b, c
Mortality
All admitted patients 31.5 21.0 6.9 a, b, c
General floor 26.40 18.30 6.50 a, b, c
Direct ICU admission 66.70 37.20 25 a, b
ICU upgrade 58.30 30.80 20.80 a, b
Non-upgrade general floor 14.70 9.50 6.00 b
Total ICU admission 61.30 32.70 22.50 a, b
Adjusted mortality Adjusted OR [95% CI] Adjusted p
(B)
HA-AKI and no AKI 4.67 [3.1, 7.0] < 0.001
HA-AKI and CA-AKI 1.61 [1.10, 2.35] 0.014
CA-AKI and no AKI 3.39 [2.22, 5.21] < 0.001

ORs and p values were adjusted for covariates (see Methods).

p < 0.05 for abetween CA-AKI and HA-AKI, bbetween HA-AKI and no AKI, and cbetween CA-AKI and no AKI.